[{"id":"4a96be15-3189-42fb-8719-80265307cf12","acronym":"","url":"https://clinicaltrials.gov/study/NCT05494320","created_at":"2022-08-09T17:04:59.070Z","updated_at":"2024-07-02T16:36:05.790Z","phase":"","brief_title":"the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin","source_id_and_acronym":"NCT05494320","lead_sponsor":"Ain Shams University","biomarkers":" ABCC2","pipe":"","alterations":" ","tags":["ABCC2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 5-fluorouracil • oxaliplatin"],"overall_status":"Recruiting","enrollment":" Enrollment 120","initiation":"Initiation: 08/15/2021","start_date":" 08/15/2021","primary_txt":" Primary completion: 08/05/2022","primary_completion_date":" 08/05/2022","study_txt":" Completion: 12/31/2022","study_completion_date":" 12/31/2022","last_update_posted":"2022-08-09"},{"id":"296c96e7-b22e-4040-a519-2e7ecf12e1f7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03147378","created_at":"2021-10-19T13:55:36.804Z","updated_at":"2024-07-02T16:36:22.779Z","phase":"Phase 1","brief_title":"Food Effect Study of ModraDoc006 in Combination With Ritonavir","source_id_and_acronym":"NCT03147378","lead_sponsor":"Modra Pharmaceuticals","biomarkers":" ABCB1 • ABCC2","pipe":"","alterations":" ","tags":["ABCB1 • ABCC2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel oral/ritonavir (ModraDoc006/r)"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 05/10/2017","start_date":" 05/10/2017","primary_txt":" Primary completion: 04/04/2018","primary_completion_date":" 04/04/2018","study_txt":" Completion: 04/04/2018","study_completion_date":" 04/04/2018","last_update_posted":"2021-10-19"}]